A Flow Process Using Microreactors for the Preparation of a Quinolone Derivative as a Potent 5HT1B> Antagonist

• Zizheng Qian
• Ian R. Baxendale
• Steven V. Ley

• Innovative Technology Centre, Department of Chemistry, University of Cambridge

This article describes the continuous flow synthesis of ­6-methoxy-8-(4-methyl-1,4-diazepan-1-yl)-N-(4-morpholinophen-yl)-4-oxo-1,4-dihydroquinoline-2-carboxamide, a potent 5HT_1B antagonist developed by AstraZeneca.

Read the publication that featured this abstract